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Abstract
This is the protocol for a Campbell review. The primary aim is to estimate the relative
efficacy of different modes of CBT delivery compared with control conditions for
reducing depressive symptoms in adolescents. The secondary aim is to compare the
different modes of delivery with regards to intervention completion/attrition (used as
a proxy for intervention acceptability). The review will provide relative effect
estimates and ranking probabilities for each outcome based on intervention delivery.
1 | BACKGROUND
1.1 | Description of the condition
Depression is a public health problem and common among adolescents.
It is estimated that around one in ten adolescents in the USA experience
at least one major depressive episode per year (Center for Behavioral
Health Statistics and Quality, 2015). In Europe, the prevalence of
depression in adolescents has been reported using baseline data from a
randomised controlled trial (RCT), which found the prevalence ranging
from 7.1–19.4% across 11 countries (Balázs et al., 2012).
An analysis in the United States found the lifetime prevalence of
major depressive disorder to be 16.6%, with a median age of onset of 32
years (Kessler et al., 2005). In terms of prevalence in children and young
people, an analysis of 26 epidemiological studies of children and
adolescents born between 1965 and 1996 found that rates of
depression (any depression, major depressive disorder, or major
depressive episode), established through diagnostic interview, have not
increased over a 30‐year period (Costello, Erkanli, & Angold, 2006). This
study found that the prevalence of depression in adolescents was 5.7%.
A diagnosis of major depressive disorder, according to the DSM‐V
criteria, is characterised by the presence of five or more symptoms,
such as a persistent depressed mood, a loss of interest or pleasure in
daily activities, sleep problems, change in appetite or weight, fatigue,
feelings of worthlessness or guilt, diminished concentration and
suicidal thoughts, consistently for at least a 2‐week period (American
Psychiatric Association 2013). Clinically significant distress or
impairment in social, occupational, or other important areas of
functioning must also be present.
The incidence of major depressive disorder in children and
adolescents is associated with lifetime psychiatric comorbidity, risk
of suicidality, functional impairments and recurrence (Rohde,
Lewinsohn, Klein, Seeley, & Gau, 2013). An analysis of global data
found that neuropsychiatric disorders were the main cause of disease
burden for young people aged 10 to 24 years, with most of these
accounted for by unipolar depressive disorders (Gore et al., 2011).
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In addition, a history of depressive episodes or elevated
symptoms of depression are significant risk indicators of later major
depressive disorder and can have a negative impact on the quality of
life (Bertha & Balázs, 2013). An analysis from the Christchurch
Health and Development Study birth cohort in New Zealand found
that subthreshold depression in young people aged 17 to 18 was
associated with later depression and suicidal tendencies up to age 25
(Fergusson, Horwood, Ridder, & Beautrais, 2005). However, a
prospective longitudinal cohort study in Australia found that
although the diagnosis of depression in adolescence predicts
diagnosis in young adulthood, the rates of disorder dropped by the
late 20s (Patton et al., 2014). Remission was most likely in cases
where adolescent depression was brief in duration.
The evidence for the incidence, impact and prognosis of
adolescent depression continue to indicate that it is important to
identify the most effective interventions to reduce depressive
symptoms and limit the duration of diagnoses to improve quality of
life in adolescence and into adulthood.
1.2 | Description of the intervention
The focus of this review will be on interventions that are based on
cognitive behavioural therapy (CBT) and delivered through various
modalities. CBT is widely used to treat depression among children,
adolescents and adults and is one of several interventions recom-
mended for treating depression in children and adolescents by the
National Institute for Health and Care Excellence in the UK and the
American Academy of Child and Adolescent Psychiatry (Birmaher &
Brent, 2007; NICE 2017).
CBT is a psychotherapy based on the premise that cognitions,
behaviour patterns and emotions are linked, and that cognitive and
behavioural techniques can produce changes in these links (Kendall &
Panichelli‐Mindel, 1995). According to this model, adolescents with
depressive symptomology have negative perceptions about them-
selves, the world and the future, which affect behaviours and sustain
the feelings of low self‐esteem and hopelessness (Dobson & Dozois,
2001). For example, depressed individuals will be selective in
choosing the evidence for their performance, such that only those
instances that support poor performance are remembered, which
leads to behaviours that contribute to the development and
persistence of depression, such as reduced engagement in activities.
This reduced engagement reduces the chance of positive reinforce-
ment. A reduction in positive reinforcement for healthy behaviours
may lead to depressive symptomology, and depressed individuals
often give up activities that they value. Thus, CBT aims to modify the
relationship between thoughts, behaviours and emotions.
1.3 | How the intervention might work
This review is concerned with examining various delivery modalities
of CBT. CBT can be delivered by a therapist in groups or individually,
or through self‐help. Therapist support may be delivered face‐to‐face
or remotely, which can be real‐time or delayed. Furthermore, CBT
can be delivered via telephone calls or text messages with a
therapist, or via the web through web‐based programmes that may
or may not include communication with a therapist (Rathbone, 2017).
Potential reasons for virtual appointments are to improve accessi-
bility to therapy and reduce costs. The dose (number, duration and
frequency of sessions) of CBT varies and the dose‐response
relationship is not well understood (Girlanda et al., 2016).
The content and dose are often similar between face‐to‐face and
remote therapy. Self‐help is a mode of delivery that is independent of
professional contact and can be delivered via books, computer
programmes, or other media. Therapist support can be provided
alongside self‐help to guide the patient through the intervention
(Cuijpers, Donker, van Straten, Li, & Andersson, 2010). Self‐help CBT
can be standardised (i.e., the material is not tailored to individuals
and is the same package for all) or personalised (i.e., the material is
tailored to individual needs), and it may or may not be interactive.
1.4 | Why it is important to do this review
Existing research does not provide clear conclusions regarding the
relative effectiveness of the different delivery modalities of CBT for
depression in children and adolescents.
A network meta‐analysis of psychotherapies for depression in
children and adolescents found that only interpersonal therapy and
CBT were significantly more effective than control conditions and
were more effective in reducing depressive symptoms than alter-
native psychotherapies such as play therapies and problem‐solving
therapy (Zhou et al., 2015). However, the review included different
delivery modalities of each psychotherapy in the same node and
therefore could not draw conclusions about the relative effectiveness
of these modalities.
A recent systematic review looked at the effectiveness of
computerised therapies for anxiety and depression in children and
young people (Pennant et al., 2015). It identified studies testing three
programmes for depression and two programmes aimed at both
anxiety and depression; these included interactive games and
standardised educational programmes. All of the programmes for
depression were rated by the authors as having low therapist input.
One programme for depression and anxiety in the general population
was rated as having low therapist input, but the remaining two
programmes were for populations at risk of anxiety and depression
and involved some therapist input. The review found that compu-
terised CBT was more effective than nontherapeutic controls, but that
face‐to‐face therapy was more effective than computerised CBT. A
limitation of the review is that it looked at computerised therapies as a
whole, rather than categorising them according to whether they were
solely self‐help interventions or included therapist support. Similarly, a
review of online and social networking interventions for depression in
young people found that online interventions with a cognitive
behavioural focus were promising in terms of reducing depression
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(Rice et al., 2014). This review included studies with varying levels of
support, usually from moderators or tutors. It also found a lot of
variation between interventions in terms of dropout rates and it was
not clear whether the level of support was related to attrition.
Another review that found computerised CBT interventions to
be effective in reducing depressive symptoms in children and
young people up to age 25 did not differentiate between therapist‐
guided and unguided self‐help formats of CBT interventions (Ebert
et al., 2015). Similarly, a review of computerised CBT for anxiety
and depression found that included studies varied considerably in
terms of therapist support (Richardson, Stallard, & Velleman,
2010). This is potentially important because there is some
evidence based on an analysis of computerised psychotherapies
with adults that the effect on depressive symptoms is moderated
by the level of therapist support, with larger effects associated
with therapist involvement (Andersson & Cuijpers, 2009). A survey
of young people using Child and Adolescent Mental Health
Services in the UK also found that most young people would
prefer to talk to a therapist, with only 9% preferring to use a
computer programme on their own (Stallard, Velleman, &
Richardson, 2010).
Existing reviews are limited by the lack of primary research
comparing the effectiveness of multiple modes of delivering CBT
directly, with most studies comparing computerised forms of CBT
that are either purely self‐help or self‐help with therapist support
with waitlist, no treatment, or treatment as usual controls (Calear &
Christensen, 2010; Fleming et al., 2014). While there are studies that
compare the effectiveness of a particular mode of delivery of CBT to
no intervention (e.g., van der Zanden, Kramer, Gerrits, & Cuijpers,
2012) or another non‐CBT control condition (e.g., Reynolds & Coats,
1986), few studies conduct a head‐to‐head evaluation of two
different modes of delivering CBT.
These existing reviews (Calear & Christensen, 2010; Ebert et al.,
2015; Fleming et al., 2014; Pennant et al., 2015; Rice et al., 2014) all
combine self‐help with therapist support and self‐help without
therapist report, making it impossible to determine the relative
effectiveness of these two delivery modes and leaving open the
questions as to whether the addition of therapist support leads to
greater effectiveness or patient engagement.
To address this gap, this review will conduct a network meta‐
analysis, a method that includes direct and indirect evidence of the
relative effectiveness of different interventions and thus allows
comparison of pairs of interventions where there are few or no
studies that have tested the two interventions in a head‐to‐head trial.
This method will also allow for examination of the ranking
probabilities of competing modes of delivering CBT based on their
relative effectiveness for reducing depression among adolescents
(Salanti, Ades, & Ionnidis, 2011).
The findings of this review will have implications for policy and
practice and the future funding of mental health service provision by
providing an understanding of how different CBT delivery modes
compare with one another on a subpopulation of adolescents with
elevated symptoms of depression. As delivery modalities will differ in
terms of demands on resources, this review may have important
cost‐benefit implications, which could be examined in further
research (Arnberg, Linton, Hultcrantz, Heintz, & Jonsson, 2014).
2 | OBJECTIVES
The current review aims to estimate the relative efficacy of different
modes of CBT delivery compared with control conditions for
reducing depressive symptoms in adolescents. The review will
provide relative effect estimates and ranking probabilities on the
effectiveness of interventions to reduce depressive symptoms in
adolescents based on intervention delivery.
Primary question
1. In terms of reducing depressive symptoms in adolescents with
elevated symptoms of depression, how do cognitive behavioural
interventions differentiated by delivery modes compare to one
another and to control groups?
Secondary question
2. With regards to intervention completion/attrition (used as a
proxy for intervention acceptability), how do cognitive behaviour-
al interventions (for depressive symptoms in adolescents with
elevated symptoms of depression) differentiated by delivery
modes compare to one another and to control groups?
3 | METHODS
3.1 | Criteria for considering studies for this review
3.1.1 | Types of studies
This review will look exclusively at RCTs with pre‐ and postdata,
including cluster RCTs (i.e., where groups of participants, such as a
classroom, rather than individuals, are the unit of random allocation).
Quasi‐randomised trials (i.e., use of quasi‐random methods of
allocation such as alternation, date of birth, case record number)
and controlled clinical trials will be ineligible in order to minimise bias
that could threaten the validity of the network meta‐analysis. Cross‐
over studies (i.e., where study groups receive two or more
interventions in different sequences) will be included only if they
are RCTs and if they provide data at the end of the first stage.
Multiarm trials will be included.
3.1.2 | Types of participants
The population of interest is adolescents with elevated, clinically
relevant symptoms of depression as measured by validated self‐
reported measures or diagnostic instruments. We will include
adolescents who meet diagnostic criteria for major depressive
disorder.
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3.2 | Age
All studies conducted with adolescents aged 10 to 19 years will be
included, in line with the WHO definition of adolescence. Studies
conducted with secondary, middle or high school students will also be
included (where the age range may differ slightly). Where studies
include younger children or adult populations along with adolescents,
they will be included only if the data on adolescents are reported
separately.
3.3 | Specific characteristics
Studies that include participants of a specific characteristic (e.g.,
participants of a particular ethnicity or those in families where
parents have divorced) will not be excluded unless the intervention
has been designed specifically for the population or has made
adaptations to the content of the intervention and a threat to the
transitivity assumption is therefore present.
3.4 | Diagnosis
This review will focus on adolescents with elevated symptoms of
depression, that is, clinically relevant symptoms of depression that
may or may not meet diagnostic criteria for major depressive
disorder. Elevated symptoms of depression may be established using
diagnostic instruments or scores on self‐report measures.
The diagnostic instruments that will be considered are as follows.
• The Schedule for Affective Disorders and Schizophrenia for
School‐age Children.
• The Diagnostic Interview Schedule for Children.
• The Diagnostic Interview for Children and Adolescents‐Revised.
• The Child and Adolescent Psychiatric Assessment.
We will include studies with participants scoring in the clinical
range of symptoms of depression based on self‐reported measures.
Table 1 lists score cut points for some common self‐reported
measures that will be included. The eligibility criteria will be
considered first, followed by the baseline scores to identify if the
mean score is above the cut point. If other measures are used, they
will be considered for inclusion based on their validity as measures of
depression in adolescents.
In cases where the information provided in the study is unclear
and the author does not provide further clarification, we will include
studies if participants are included based on depressive symptoms.
Studies using measures that have not been validated as a
depression measure for children and adolescents against a diagnostic
tool, which have a low reliability (e.g., the Bellevue Index of Depression
—low reliability reported in Kazdin, French, Unis, & Esveldt‐dawson,
1983), or where the method to establish elevated symptoms of
depression is unclear will be excluded in a sensitivity analysis.
Other mental health constructs such as “attributional style” are
not considered as elevated depressive symptoms and thus will be
excluded. Studies that include adolescents who are deemed to be at
risk of developing any form of depressive disorder but who do not
display elevated symptoms will be excluded. The exception to this is
when the mean depression score at baseline for the intervention and
comparison groups falls in the elevated level of depressive symptoms
mentioned above.
Studies with adolescents with any comorbid disorders (e.g.,
depression and anxiety, depression and schizophrenia) will only be
included if the focus of the intervention is the treatment of
depression, not comorbid conditions.
Studies will also be excluded if their inclusion criteria include
adolescents with cognitive impairments (e.g., learning difficulties
and autism), or adolescents with chronic or acute physical health
conditions, or if the reports state that adolescents with these types
of impairments or conditions were part of the study sample. The
purpose of this last criterion is to limit the variation in populations
within and across studies in the network, as it is an important effect
modifier that has implications for the validity of the network
meta‐analysis.
3.4.1 | Types of interventions
The review will include cognitive behavioural interventions that aim
to reduce symptoms of depression in adolescence, irrespective of
delivery mode. For the purposes of this review, an intervention will
be considered a cognitive behavioural intervention if it includes (a)
evaluation of cognition to identify dysfunctional cognition, (b)
cognitive restructuring to adopt helpful cognition and (c) a
component focusing on behaviour: behavioural activation, problem
solving, social skills training or relaxation techniques. We recognise
that variation in the third component may confound the estimated
difference between treatment delivery modes, and if we are able to
identify these types of differences between the interventions, we will
test this using sensitivity analyses. Similarly, if the description of the
intervention is not clear but is described as having a more cognitive
or behavioural focus but is likely to be CBT, we will include the
relevant studies and test in sensitivity analyses as these interven-
tions may be partial CBT with more cognitive or more behavioural
foci (Hetrick et al., 2015).
If the description of the intervention in source documents is not
adequate to make an assessment on inclusion based on the above
criteria, the author(s) will be contacted. If we do not receive further
details from the author(s), we will include studies that identify the
intervention as CBT and exclude studies that do not identify the
intervention as CBT.
Studies evaluating interventions that do not have all three CBT
components listed above, or which are not identified by the authors
as CBT, will be excluded.
In line with the above conceptualisation of CBT, interventions such
as acceptance and commitment therapy, mindfulness‐based cognitive
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therapy and dialectical behaviour therapy that are rooted in principles
different from those of CBT and focus on helping people to accept
thoughts in a nonjudgemental manner will be excluded (e.g., Hayes,
Strosahl, & Wilson, 1999; Linehan et al., 2006; Segal, Williams, &
Teasdale, 2012).
Interventions will be placed according to their mode of delivery
into the following five categories.
1. Therapist‐delivered CBT in one‐to‐one sessions: This includes
CBT delivered by a therapist to individual clients either in face‐to‐
face sessions or remotely but in real‐time (for example, audio or
video call, live messaging).
2. Therapist‐delivered CBT in group sessions: This is similar to the
above, but sessions are conducted for a group of clients rather
than an individual client.
3. Therapist‐led CBT delivered remotely: This includes CBT that is
delivered by a therapist remotely—for example, emails, Skype and
text messaging. The delivery can be to individual clients or groups
of clients. If an intervention combines real‐time and delayed
support, it will be categorised based on the primary intended
means of therapist contact.
4. Unguided self‐help: This involves educating the client in the
principles of CBT through reading material and helping them
apply it through quizzes and activities. Traditionally, this was
referred to as bibliotherapy and included workbooks. CBT can
now be provided through various technological platforms (such as
smartphone applications or browser‐based programmes), and
include audio files and videos in addition to text. When delivered
electronically, self‐help may include additional features such as
reminders and some basic guidance on how to use the materials.
5. Self‐help with therapist support: This involves material to
introduce and guide the client through CBT, alongside support
from a therapist. For example, clients might gain an understanding
of the approach to thoughts via the workbook and could be given
homework and have regular feedback calls with a therapist.
Comparisons will be classified as (a) no intervention, (b)
treatment as usual and (c) placebo. In order to be included in the
current review, studies must do one of the following.
1. Compare two cognitive behavioural interventions delivered
through different delivery modes. Studies comparing two versions
of cognitive behavioural interventions that have the same
delivery mode will not be included in the network meta‐
analyses. If such a study also has another relevant intervention
or control group, the two different groups with a common
delivery mode will be considered as one intervention for the
analysis. The way in which the common effect size will be
determined is explained below.
2. Compare a cognitive behavioural intervention with a no inter-
vention, placebo, services as usual control group. Comparisons in
which any pharmacological treatment (e.g., antidepressants),
complementary and alternative medicine (e.g., light therapy,
acupuncture) or physical interventions (e.g., yoga, exercise) are
explicitly provided (i.e., not as services as usual) will not be
considered because they are beyond the scope of this review.
Waitlist controls will be classified as no intervention controls.
Services‐as‐usual will be grouped together to avoid disconnecting
the network. Psychological placebos may include psychoeducation
or attention placebos that are not expected to have any impact on
the outcome of interest. Psychoeducation is the provision of
information about a mental health condition without the provision
of therapy. Attention placebo conditions provide similar time and
attention from a therapist to participants without the provision of
the active therapeutic intervention. Where services‐as‐usual or a
placebo are not adequately described in source documents, the
author(s) will be contacted. If sufficient detail is not obtained, the
study in question will be excluded.
Studies where CBT is implemented in combination with another
intervention will be excluded unless the comparison group also
received the additional intervention, meaning that the effects of the
other intervention would be controlled for.
A sensitivity analysis separating therapist‐led placebos and self‐
help placebos will be carried out if both types of placebos are present
in the included studies.
We assume that any adolescent who meets the inclusion criteria
is, in principle, equally likely to be randomised to any of the eligible
interventions.
Figure 1 shows all possible intervention and control comparisons.
3.4.2 | Types of outcome measures
Primary outcomes
The primary outcome for the review will be depressive symptom final
score at postintervention and at 6 to 12 month follow‐up assessments.
To be included in the analysis, assessment of depressive symptoms
must be self‐report using a validated measure, such as most of those
listed in Table 1 (the CDRS‐R and the HDRS will not be included as
outcome measures as they are not self‐report measures). We will
consider other measures of depression symptoms for inclusion in the
analysis if used by studies and validated. In cases where there are
multiple measurement points within the 6 to 12 month timeframe, we
will use the measurement point closest to 12 months.
Where insufficient information is provided for endpoint values, we
will contact the author(s) for the required data. If those data cannot be
provided, we will describe the results in the narrative summary.
Only continuous measures of depression symptoms assessed
using a validated assessment or diagnostic tool will be considered. In
cases where a study uses multiple appropriate measures for
depressive symptoms, we will prioritise the measure that is most
used across all included studies for consistency across the network.
In cases where one particular measure used in a study is not more
common in the network than another, we will use the measure that
the authors of the study consider to be the primary measure.
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Secondary outcomes
The secondary outcome is acceptability of the intervention. This will
be defined as completing the intervention. This will be operationa-
lised as intervention discontinuation or attrition or the number of
participants who dropped out of the study by posttest as a
dichotomous outcome (Kaltenthaler et al., 2008).
Search methods for identification of studies
Electronic searches.
A search of the following electronic databases will be conducted by the
Cochrane Common Mental Disorders Group Trials Search Coordinator.
• PsycINFO
• EMBASE
• PubMED (overlaps with MEDLINE)
• International Bibliography of Social Science (IBSS)
• Cumulative Index to Nursing and Allied Health Literature
(CINAHL)
• Health Technology Assessment (HTA) Database
• The Cochrane Central Register of Controlled Trials (CENTRAL)
PsychINFO and Embase will be searched through OVID and
PubMED through NCBI. IBSS will be searched using the ProQuest
platform, while CINAHL will be via EBSCOhost. HTA is hosted by the
Centre for Reviews and Dissemination at the University of York.
The following trial registries will be searched.
• ClinicalTrials.gov
• International Clinical Trials Registry Platform (WHO)
Search strategies will be tailored for each of the databases. The
main search strategy will be as follows.
INTERVENTION: [(cognitive OR behavio(u)r*) AND (therapy OR
bibliotherapy OR intervention OR program* OR prevention OR
treatment OR self‐help OR psychoeducation OR modification OR
training)] or CBT
POPULATION: [(child* OR adolescen* OR preadolescen* OR
minor* OR young* OR youth OR student* OR teen* OR girl* OR boy*
OR male* OR female* OR school OR juvenile*) AND (depression OR
depressive OR depressed OR low mood OR mood disorder OR
dysthymi*)]
STUDY DESIGN: random* OR control OR experiment* OR clinical
study OR trial OR RCT
Searching other resources
The following sources will be hand‐searched (applying appropriate filters).
• Headspace (Australian National Youth Mental Health Foundation)
Research Database—the research database for an evidence map of
published systematic reviews and controlled studies on depression
interventions for young people (Callahan, Liu, Purcell, Parker, &
Hetrick, 2012). The database will be filtered for depression, CBT
and trials and then hand‐searched.
• www.evidencebasedpsychotherapies.org—a database on RCTs of
psychotherapies; this will be filtered by depression and then hand‐
searched.
We will search the reference lists of the following recent reviews
on psychotherapies for depression in children and young people:
Calear and Christensen 2010, Ebert et al., 2015, Fleming et al., 2014,
Pennant et al., 2015, Rice et al., 2014 and Zhou et al., 2015, as well as
reviews retrieved in the search. We will also use Google Scholar with
appropriate search terms from the search strategy to identify newer
studies that have cited these reviews.
References of all included studies will be checked to identify
further studies.
Grey literature will be identified through handsearching and
review of reference lists as described above and by contacting
authors of these reviews and included studies. Additional methods to
F IGURE 1 Draft network including all treatment and control nodes. CBT, cognitive behavioural therapy
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identify grey literature will include searching ProQuest Dissertations
and Theses (Global and UK & Ireland), Index to Theses in Great
Britain and Ireland, Educational Technology and E‐Learning (EdITLib),
PsycEXTRA, Open Grey and Google (using advanced search).
Any studies identified after completion of analysis will be
included in the review as “studies awaiting classification”. References
will be managed using Endnote X7 and Mendeley.
3.4.3 | Data collection and analysis
Selection of studies
We will use Cochrane’s Screen4Me workflow to help assess the
search results. Screen4Me comprises three components: known
assessments—a service that matches records in the search results to
records that have already been screened in Cochrane Crowd and
been labelled as an RCT or as Not an RCT; the RCT classifier—a
machine learning model that distinguishes RCTs from non‐RCTs; and
if appropriate, Cochrane Crowd (http://crowd.cochrane.org)—
Cochrane’s citizen science platform where the Crowd help to identify
and describe health evidence.
For more information about Screen4Me and the evaluations that
have been done, please go to the Screen4Me webpage on the Cochrane
Information Specialist’s portal: https://community.cochrane.org/
organizational‐info/resources/resources‐groups/information‐specialists‐
portal/searching‐conducting. In addition, more detailed information
regarding evaluations of the Screen4Me components, can be found in
the following publications: Marshall, Noel‐Storr, Kuiper, Thomas, &
Wallace, 2018, McDonald, Noel‐Storr, & Thomas, 2017, Noel‐Storr and
the Project Transform team, 2018, Thomas et al., 2017.
Unique references will be exported to Mendeley and sent
through the Screen4Me workflow. The remaining references will
then be screened for relevance by title and abstract by two of four
independent authors (G. B., L.W., S. S. and B. R.). Screening and data
extraction will be managed and stored using Covidence.
The full text of potentially relevant articles will also be screened
independently by two of four authors (G. B., L. W., S. S. and BR) for
inclusion. Any discrepancy will be resolved by consensus and
discussion with the principal investigator. The screening checklist
will also be reviewed by the second author. Eligibility will be assessed
using a predesigned form based on the inclusion criteria. Articles
excluded at this stage will be reported in a table with reasons for
exclusion. We will report interrater reliability for study identification.
The screening process will be reported using a PRISMA flow chart.
The screening checklist will include the following.
1. Does the study include a relevant intervention?
a. Is the intervention based on CBT?
b. Does the intervention target depression?
2. Is the study conducted with adolescents, or students in secondary,
middle or high school, or is the mean age between 10 and 19
years?
a. Specify mean age.
3. Is the study conducted with participants who have elevated levels
of depression?
a. Specify screening measure and cutoff score.
4. Is the study an RCT with two different nodes in the network?
a. Confirm if RCT.
b. Specify all groups and potential nodes.
3.5 | Description of methods used in primary
research
The review will only include RCTs. The most common comparison
groups are expected to be no intervention and services‐as‐usual.
Most studies will recruit and randomise individuals based on an
assessment of depressive symptoms. Some studies might randomise
clusters (such as classrooms). Studies may use any of a number of
measures of depression, with assessments taking place before the
intervention (as screening and baseline assessment) and immediately
after the intervention. Some studies may include one or more
subsequent follow‐ups. While most studies are likely to use the same
measures before and after the intervention, some studies may use
different measures. Similarly, while most studies are likely to use one
depression scale, studies may employ more than one scale.
3.6 | Criteria for determination of independent
findings
Multiple publications of the same study will be examined as a single
study.
3.7 | Studies with two or more groups
In a multiarm trial where more than one mode of delivering CBT is
evaluated, we will keep the groups separate and account for
correlations due to multiarm trials as recommended by Salanti,
Higgins, Ades, & Ioannidis, 2008.
For multiarm trials where not all arms are relevant, we will not
include nonrelevant arms in the analysis but will include them in the
“Table of Characteristics”.
3.7.1 | Data extraction and management
Data extraction will be done initially (first 10 studies) by four authors
(G. B., L. W., S. S. and B. R.) to ensure consistency. Subsequent data
extraction will be done by one author and then checked by another
author to identify and resolve potential discrepancies, with discus-
sion with a third author if required. Study coding for network node
will be conducted by one author, with a proportion conducted by two
authors, with discrepancies being resolved by a third author. We will
report interrater reliability for node identification for those that are
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coded by two authors. A second author will also check through all
network node coding for reasoning.
Studies will be coded for study design, characteristics of
participants and intervention. The study design will include a number
of groups, sample size, attrition, recruitment and referral procedures,
unit and method of randomisation, data collection methods and
timing. Participant characteristics will include age, gender, ethnicity,
socioeconomic status, baseline depressive symptoms and eligibility
criteria. Intervention characteristics will include content, format,
delivery modality including details on provider (e.g., therapist
qualifications and training, technology platform), customisation,
setting, dosage and implementation fidelity. These details will be
coded for all intervention and control groups. Based on the data
extraction, each group will be classified as one of the network nodes.
Data extraction will be undertaken using a standard extraction
form, which will be pretested.
3.7.2 | Assessment of risk of bias in included studies
Four review authors (G. B., L. W., S. S. and B. R.) will independently
assess the risk of bias using the Cochrane Risk of Bias Tool (Higgins,
Deeks, & Altman, 2011). The following domains will be assessed.
• Selection bias: Bias due to inadequate randomisation method or
allocation concealment method.
• Performance bias: Bias due to trial participants and personnel
being aware of treatment allocation.
• Detection bias: Bias due to outcome assessors being aware of
treatment allocation.
• Attrition bias: Bias due to the amount of missing data in a trial,
differential missing data between trial arms, or inadequate
methods of handling missing data.
• Reporting bias: Bias due to selective outcome reporting.
• Other sources of bias:
a. Baseline imbalance: Bias due to imbalance in patient character-
istics which are strongly related to treatment outcomes.
b. Contamination bias: Bias due to participants randomised to one
group receiving the protocol of a different group of the trial.
c. Null bias: Bias due to incomplete implementation of treatment
group protocol.
d. Recruitment bias (cluster trials): Bias due to individuals being
recruited after clusters are randomised.
e. Incorrect analysis (cluster trials): Bias due to the analysis not
taking the clustering into account.
Items will be rated for risk of bias as “Low risk”, “Unclear risk”, or
“High risk” following the guidance in the Cochrane Risk of Bias Tool
(Higgins et al., 2011). Performance, detection and attrition bias will
be rated for each outcome extracted from a study.
We will rate the overall risk of bias for each outcome within a
study using the following key domains: selection bias, detection bias
and attrition bias. The overall risk of bias will be rated as “Low risk” if
all key domains are rated as “Low risk”, “Unclear risk” if at least one
key domain is rated as “Unclear risk” and none are rated as “High
risk”, and “High risk” if at least one key domain is rated as “High risk”.
3.7.3 | Measures of treatment effect
Relative treatment effects
We will evaluate the same effect measures for both the pairwise and
network meta‐analyses. For depressive symptom score, a continuous
outcome, we anticipate that individual studies will use different
measures and therefore we will estimate the effect using Hedges’ g
standardised mean difference. For acceptability, a dichotomous
outcome, we will estimate the odds ratio (OR). We will report the
summary effects and 95% confidence intervals (CIs) for each pair of
treatments.
Relative treatment ranking
For each outcome, we will also estimate the probabilities for all
treatments attaining each possible rank. This information will be used
to develop a hierarchy of rankings using the surface under the
cumulative ranking curve (SUCRA; Salanti et al., 2011). This approach
to ranking accounts for the uncertainty in the treatment effects. A
SUCRA value of 0% indicates the treatment is among the least
effective of the treatments while a value of 100% indicates it is
among the most effective.
3.7.4 | Unit of analysis issues
Cluster randomised trials
We will include cluster‐randomised trials in the analyses along with
individually randomised trials. Where necessary, we will adjust
standard errors using the methods described in the Cochrane
Handbook (Higgins et al., 2011) using an estimate of the intracluster
correlation coefficient derived from the trial if provided, from a
similar trial, or from a study of a similar population.
We will also acknowledge heterogeneity in the randomisation
unit and conduct a sensitivity analysis to investigate the effects of
the randomisation unit.
Cross‐over trials
Cross‐over RCTs will be included only if they provide data at the end
of the first stage. Data from the second stage, after crossover, will
not be included.
Multiarm trial
As mentioned above, when there are two variations of the same mode of
delivering of CBT along with a third relevant group, the two CBT groups
will be combined. For continuous outcomes, this will be done by using
the formulae provided in table 7.7a in the Cochrane Handbook (Higgins
et al., 2011). For dichotomous outcomes, sample sizes and number of
participants with outcome across the groups will be summed.
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3.7.5 | Dealing with missing data
In case of missing information, the author(s) of the original study will
be contacted. We will document correspondence with study authors.
We will prioritise analyses using intention‐to‐treat results. In cases
where study authors used imputation to account for missing data within
a study, we will prioritise the results based on multiple imputation, but
will consider other imputation methods (e.g., last observation carried
forward). Otherwise, we will use the available case analysis.
We will record the attrition rate and evaluate the risk of bias due
to attrition bias.
3.7.6 | Assessment of heterogeneity
Assessment of clinical and methodological heterogeneity within
comparisons
We will assess clinical and methodological heterogeneity by examin-
ing the distribution of extracted study, participant and intervention
characteristics (described above) within each direct comparison.
Assessment of transitivity across treatment comparisons
We will assess the assumption of transitivity by comparing the
distribution of the potential effect modifiers across the different
pairwise comparisons. We will assess whether interventions are
delivered similarly in trials with inactive control groups and trials
with active controls; for example, whether one‐on‐one therapist‐led
CBT is delivered similarly in trials comparing it to no intervention and
trials comparing it to standardised self‐help.
3.7.7 | Assessment of reporting biases
We will aim to minimise the potential impact of reporting biases by
conducting a comprehensive search for eligible studies and by being
alert to duplication of data. We will use comparison‐adjusted funnel
plots to explore publication bias and the possibility of small‐study
effects across the network (Chaimani & Salanti, 2015). In order for
the results of comparison‐adjusted funnel plots to be meaningful, the
treatment comparisons need to be ordered consistently based on the
anticipated direction of the small‐study effects. Therefore, anticipat-
ing that active treatments will be favoured, we will focus on active
treatment versus inactive control comparisons. We will generate
comparison‐adjusted forest plots using the netfunnel command in
Stata 13® (Chaimani & Salanti, 2015).
3.7.8 | Data synthesis
Methods for direct treatment comparisons
A pairwise meta‐analysis will be conducted for each pair of
interventions (or controls) where there are two or more head‐to‐
head trials. As we anticipate that different trials within a comparison
will not be estimating the same effect, we will use random effects
models. We will perform pairwise meta‐analyses using the metan
command in Stata 13® (Harris et al., 2008).
Methods for indirect and network comparisons
We will conduct network meta‐analyses using random effects
models. These analyses will follow the multivariate metaregression
approach accounting for correlations within multiarm trials (Lu &
Ades, 2006; White, 2011; White, Barrett, Jackson, & Higgins, 2012).
For the purpose of the analysis, we will set the most commonly used
intervention (or control) among identified trials as the reference. We
will use the “network” suite of commands in Stata 13® to conduct
the network meta‐analyses (White, 2015).
Assessment of statistical heterogeneity
Assumptions when estimating the heterogeneity.
We will conduct pairwise meta‐analyses assuming comparison‐
specific heterogeneity (i.e., each direct comparison has a separate
heterogeneity estimate). For network meta‐analyses, we will assume
a common heterogeneity across comparisons.
Measures and tests for heterogeneity.
Statistical heterogeneity within pairwise comparisons will be assessed
through χ2 tests and I2. We will consider the following thresholds when
interpreting I2: 0–40% might not be important; 30–60% may represent
moderate heterogeneity; 50–90% may represent substantial hetero-
geneity; and 75–100% represents considerable heterogeneity (Deeks,
Higgins, & Altman, 2011). We will also consider the magnitude and the
direction of the effects in our assessment of I2. To assess heterogeneity
across the entire network, we will evaluate the magnitude of τ2 and
compare it with the empirical distribution (Rhodes, Turner, & Higgins,
2015; Turner, Davey, Clarke, Thompson, & Higgins, 2012).
Assessment of statistical inconsistency.
We will evaluate inconsistency using a combination of local and
global approaches. If we detect inconsistency, we will carefully re‐
evaluate the set of studies indicated by the tests which may be the
source of inconsistency.
Local approaches for evaluating inconsistency.
We will evaluate inconsistency locally using the loop‐specific
approach and the node‐splitting approach.
The loop‐specific approach involves examining each closed loop of at
least three treatments to determine the agreement between direct and
indirect evidence (Higgins et al., 2012). The difference between the direct
and indirect estimate is represented by the inconsistency factor and its
95% CI and if the 95% CI is not compatible with 0, it indicates the
presence of potential inconsistency. We will implement the loop‐specific
approach using if plot in Stata 13® (Chaimani & Salanti, 2015).
The node‐splitting approach involves examining each pair of
treatments individually to compare the direct and indirect estimates
(Dias, Welton, Caldwell, & Ades, 2010). Significant differences
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indicating potential inconsistency are detected using a z test. We will
implement the node‐splitting approach using the network sidesplit
command in Stata 13® (White, 2015).
Global approaches for evaluating inconsistency.
We will evaluate inconsistency in the entire network simultaneously
using a design‐by‐treatment interaction model. This model adds
terms to represent disagreement between direct and indirect
evidence as well as differences by trial design (e.g., two‐arm versus
three‐arm trials; Higgins et al., 2012). A Wald test is used to assess
potential inconsistency. We will fit inconsistency models using the
“network” suite in Stata 13® (White, 2015).
Summary of findings
The main summary of findings table will be based on GRADE
recommendations. The table will include the quality of evidence, effect
size (against a control group), sample size and direct or indirect evidence,
with further details summarised in a narrative and additional tables
(capturing the intervention details and study details). The adaptation of
GRADE to network meta‐analysis will be implemented using the
CINeMA web application (http://cinema.ispm.ch/). We will also assess
the certainty of treatment rankings based on the Salanti framework
(Salanti, Giovane, Chaimani, Caldwell, & Higgins, 2014). The geometry of
the network will be described according to the PRISMA guidelines
(Hutton et al., 2015). We will also present the findings including effect
size (against a control group), confidence intervals, SUCRA rankings and
quality of evidence using a bar graph. We will summarise the relative
effectiveness of all interventions against each other in a matrix.
3.7.9 | Subgroup analysis and investigation of
heterogeneity
One potential effect modifier is participant age (Curry et al., 2006).
We will conduct some exploratory subgroup analyses to investigate
the effect of participant age on the primary outcome. Subgroup
analyses will be conducted to investigate differences by splitting
studies according to mean age of participants as follows: 10 to 13
years; 14 to 15 years; ≥16 years. These subgroups are based on a
study that found differences between age subgroups on response to
treatment for depression in adolescents (Curry et al., 2006). We will
examine the differences in the results of these subgroup analyses
qualitatively and if there are substantial differences, we may re‐
evaluate transitivity. For example, if the analysis of the youngest
participants has substantially different results from that of the older
groups, we may exclude these studies from the primary analysis.
3.7.10 | Sensitivity analysis
As mentioned above, if we are able to identify differences between
interventions in terms of components such as behavioural activation,
problem solving, social skills training or relaxation techniques, we will
test whether these differences may confound the estimated
difference between delivery modes using sensitivity analyses.
In addition, all placebo control conditions will be grouped
together in the same node in the network, but a sensitivity analysis
separating therapist‐led placebos, self‐help placebos and pill placebos
will be carried out if these different types of placebos are present in
the included studies.
We will also conduct a sensitivity analysis to exclude studies
where symptoms of depression were established using an unvali-
dated measure or unclear method.
We will also conduct a sensitivity analysis to exclude studies
where we have coded the intervention as customised to examine
whether customisation of interventions may confound the estimated
difference between delivery modes.
Finally, we will conduct a sensitivity analysis to investigate the
effects of the randomisation unit if cluster‐randomised and individu-
ally randomised trials are identified and included in the analysis.
Sensitivity analyses will be conducted for the primary outcome at
the postintervention time point.
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analysis and has written guidance for clinicians in conducting and
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Additional tables
1 Examples of measures of depression
Measure Score cut point
Beck Depression Inventory
Second Edition
≥14 (http://academicdepartments.
musc.edu/family_medicine/rcmar/
beck.htm)
Centre for Epidemiologic Studies
Depression Scale Revised
≥16 (http://cesd‐r.com/cesdr/)
Children’s Depression Inventory ≥16 (Ivarsson, Svalander, and
Litlere (2006); Roelofs et al.,
2010)
Children’s Depression Rating
Scale‐Revised
≥30 (based on author
correspondence)
Children’s Depression Scale ≥135 (Tisher, Lang‐Takac, & Lang,
1992)
Hamilton Depression Rating Scale ≥8 (Hamilton 1960; Sharp 2015)
*Dependent on the version of
the HDRS used in the study
Mood and Feelings Questionnaire ≥27 (based on author
correspondence)
≥5 on the short version (SMFQ;
Thapar & McGuffin, 1998)
Reynolds Adolescent Depression
Scale (RCDS)
t score of 61 equivalent to a raw
score of 76 (Reynolds 2004)
Patient Health Questionnaire–9 ≥5 (Kroenke & Spitzer, 2002)
Patient Health Questionnaire for
Adolescents (PHQ‐A, also called
the Severity Measure for
Depression)
≥5 (Johnson, Harris, Spitzer, &
Williams, 2002)
Sources of support
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